Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer’s Disease

por Söderberg, Linda, Johannesson, Malin, Nygren, Patrik, Laudon, Hanna, Eriksson, Fredrik, Osswald, Gunilla, Möller, Christer, Lannfelt, Lars
Publicado 2022

Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease

por Lannfelt, Lars, Möller, Christer, Basun, Hans, Osswald, Gunilla, Sehlin, Dag, Satlin, Andrew, Logovinsky, Veronika, Gellerfors, Pär
Publicado 2014

The interwoven fibril-like structure of amyloid-beta plaques in mouse brain tissue visualized using super-resolution STED microscopy

por Johansson, Björn, Oasa, Sho, Muntsant Soria, Aida, Tiiman, Ann, Söderberg, Linda, Amandius, Ebba, Möller, Christer, Lannfelt, Lars, Terenius, Lars, Giménez-Llort, Lydia, Vukojević, Vladana
Publicado 2023